Studying fatty aldehyde metabolism in living cells with pyrene-labeled compounds

Markus A. Keller, Katrin Watschinger, Karsten Lange, Georg Golderer, Gabriele Werner‐Felmayer, Albin Hermetter, Ronald J. A. Wanders, Ernst R. Werner

Journal of Lipid Research · 2012 · 18 citations · 21 references

DOIFull text

Open access

Concepts

Abstract

The lack of fatty aldehyde dehydrogenase function in Sjögren Larsson Syndrome (SLS) patient cells not only impairs the conversion of fatty aldehydes into their corresponding fatty acid but also has an effect on connected pathways. Alteration of the lipid profile in these cells is thought to be responsible for severe symptoms such as ichtyosis, mental retardation, and spasticity. Here we present a novel approach to examine fatty aldehyde metabolism in a time-dependent manner by measuring pyrene-labeled fatty aldehyde, fatty alcohol, fatty acid, and alkylglycerol in the culture medium of living cells using HPLC separation and fluorescence detection. Our results show that in fibroblasts from SLS patients, fatty aldehyde is not accumulating but is converted readily into fatty alcohol. In control cells, in contrast, exclusively the corresponding fatty acid is formed. SLS patient cells did not display a hypersensitivity toward hexadecanal or hexadecanol, but 3-fold lower concentrations of the fatty alcohol than the corresponding fatty aldehyde were needed to induce toxicity in SLS patient and in control cells. The lack of fatty aldehyde dehydrogenase function in Sjögren Larsson Syndrome (SLS) patient cells not only impairs the conversion of fatty aldehydes into their corresponding fatty acid but also has an effect on connected pathways. Alteration of the lipid profile in these cells is thought to be responsible for severe symptoms such as ichtyosis, mental retardation, and spasticity. Here we present a novel approach to examine fatty aldehyde metabolism in a time-dependent manner by measuring pyrene-labeled fatty aldehyde, fatty alcohol, fatty acid, and alkylglycerol in the culture medium of living cells using HPLC separation and fluorescence detection. Our results show that in fibroblasts from SLS patients, fatty aldehyde is not accumulating but is converted readily into fatty alcohol. In control cells, in contrast, exclusively the corresponding fatty acid is formed. SLS patient cells did not display a hypersensitivity toward hexadecanal or hexadecanol, but 3-fold lower concentrations of the fatty alcohol than the corresponding fatty aldehyde were needed to induce toxicity in SLS patient and in control cells. The autosomal, inherited disease Sjögren Larsson Syndrome (SLS; OMIM: 270200) is caused by mutations in the ALDH3A2 gene (1.Rizzo W.B. Lin Z. Carney G. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.Chem. Biol. Interact. 2001; 130–132: 297-307Crossref PubMed Scopus (26) Google Scholar). This gene codes for the enzyme fatty aldehyde dehydrogenase (FALDH; [EC 1.2.1.48]), which catalyzes the irreversible, NAD-dependent conversion of a wide range of different fatty aldehydes into their corresponding fatty acids (2.Rizzo W.B. Craft D. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.J. Clin. Invest. 1991; 88: 1643-1648Crossref PubMed Scopus (134) Google Scholar, 3.Kelson T.L. Secor McVoy J. Rizzo W. Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization.Biochim. Biophys. Acta. 1997; 1335: 99-110Crossref PubMed Scopus (117) Google Scholar). This enzyme is active as a homodimer (4.Keller M.A Watschinger K. Golderer G. Maglione M. Sarg B. Lindner H. Werner-Felmayer G. Terrinoni A. Wanders R. Werner E. Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal.J. Lipid Res. 2010; 51: 1554-1559Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar) and is bound to membranes by its hydrophobic carboxy-terminus (5.Ashibe B. Hirai T. Higashi K. Sekimizu K. Motojima K. Dual subcellular localization in the endoplasmic reticulum and peroxisomes and a vital role in protecting against oxidative stress of fatty aldehyde dehydrogenase are achieved by alternative splicing.J. Biol. Chem. 2007; 282: 20763-20773Abstract Full Text Full Text PDF PubMed Scopus (58) Google Scholar). More than 70 mutations are known that impair fatty aldehyde dehydrogenase function (6.Rizzo W.B. Carney G. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2).Hum. Mutat. 2005; 26: 1-10Crossref PubMed Scopus (102) Google Scholar), thereby having a severe impact on the metabolism of lipids in cells (7.Rizzo W.B. Craft D. Somer T. Carney G. Trafrova J. Simon M. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.J. Lipid Res. 2008; 49: 410-419Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar). Accumulating fatty aldehydes in SLS patients are suspected to cause a wide range of symptoms, such as ichtyosis, mental retardation, and spasticity (8.Sjögren T. Larsson T. Oligophrenia in combination with congenital ichthyosis and spastic disorders; a clinical and genetic study.Acta Psychiatr. Neurol. Scand., Suppl. 1957; 113: 1-112PubMed Google Scholar), by chemical interaction with free amino-groups of lipids and proteins (9.James P.F. Zoeller R. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sjogren-Larsson syndrome.J. Biol. Chem. 1997; 272: 23532-23539Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar). The crucial role of fatty aldehyde dehydrogenase in multiple lipid pathways is not only emphasized by the diversity of symptoms but also by the targeted localization of fatty aldehyde dehydrogenase splice variants to the endoplasmatic reticulum and to peroxisomes, respectively (5.Ashibe B. Hirai T. Higashi K. Sekimizu K. Motojima K. Dual subcellular localization in the endoplasmic reticulum and peroxisomes and a vital role in protecting against oxidative stress of fatty aldehyde dehydrogenase are achieved by alternative splicing.J. Biol. Chem. 2007; 282: 20763-20773Abstract Full Text Full Text PDF PubMed Scopus (58) Google Scholar), and its role in diabetes induced lipid peroxidation (10.Demozay D. Rocchi S. Mas J. Grillo S. Pirola L. Chavey C. Van Obberghen E. Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin.J. Biol. Chem. 2004; 279: 6261-6270Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar, 11.Demozay D. Mas J. Rocchi S. Van Obberghen E. FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3–L1 adipocytes.Diabetes. 2008; 57: 1216-1226Crossref PubMed Scopus (83) Google Scholar). Fatty aldehydes are produced in fatty alcohol metabolism (2.Rizzo W.B. Craft D. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.J. Clin. Invest. 1991; 88: 1643-1648Crossref PubMed Scopus (134) Google Scholar). They are also formed in the enzymatic cleavage of ether lipids by alkylglycerol monooxygenase (12.Watschinger K. Keller M. Golderer G. Hermann M. Maglione M. Sarg B. Lindner H. Hermetter A. Werner-Felmayer G. Konrat R. et al.Identification of the gene encoding alkylglycerol monooxygenase defines a third class of tetrahydrobiopterin-dependent enzymes.Proc. Natl. Acad. Sci. USA. 2010; 107: 13672-13677Crossref PubMed Scopus (66) Google Scholar) and in leukotriene B4 degradation (13.Willemsen M.A. Rotteveel J. de Jong J. Wanders R. IJlst L. Hoffmann G. Mayatepek E. Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome.J. Neurol. Sci. 2001; 183: 61-67Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar). The role of fatty aldehyde dehydrogenase in lipid metabolism has been studied by quantification of different lipid species in SLS patient cells by organic phase extraction of cell pellets and analysis with thin-layer chromatography and high-performance thin layer chromatography (7.Rizzo W.B. Craft D. Somer T. Carney G. Trafrova J. Simon M. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.J. Lipid Res. 2008; 49: 410-419Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar, 9.James P.F. Zoeller R. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sjogren-Larsson syndrome.J. Biol. Chem. 1997; 272: 23532-23539Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar, 14.Rizzo W.B Heinz E. Simon M. Craft D. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.Biochim. Biophys. Acta. 2000; 1535: 1-9Crossref PubMed Scopus (37) Google Scholar). Another approach was to use radiolabeled substrates, which are quantified by scintillation spectrometry, subsequent to organic phase extraction, separation by thin layer chromatography, identification of bands of interest, and scraping off selected bands (7.Rizzo W.B. Craft D. Somer T. Carney G. Trafrova J. Simon M. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.J. Lipid Res. 2008; 49: 410-419Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar, 9.James P.F. Zoeller R. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sjogren-Larsson syndrome.J. Biol. Chem. 1997; 272: 23532-23539Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar, 14.Rizzo W.B Heinz E. Simon M. Craft D. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.Biochim. Biophys. Acta. 2000; 1535: 1-9Crossref PubMed Scopus (37) Google Scholar). Here, we present a sensitive method that allowed us to follow the fate of four different fluorescent labeled substrates in the culture medium of living cells. We used this method to monitor the metabolism of fatty aldehyde and fatty alcohol in SLS patients and in control fibroblasts. Pyrenedecanol was synthesized from pyrenedecanoic acid, and 1-O-pyrenedecyl-sn-glycerol (1-O-pyrenedecylglycerol) was synthesized from pyrenedecanol and glycerol as described elsewhere (15). Pyrenedecanal was purchased from Ramidus AB (Lund, Sweden). n-Hexadecanol (2.0 g) was dissolved in 30 ml of dry CH2Cl2. Then, 1.3 ml dry DMSO was added, and mixture was cooled to 0°C in an ice bath, and 2.35 g P2O5 was added. The mixture stirred for 2 h without cooling. After completion of the reaction (TLC control), the mixture was cooled to 0°C, and 4.25 ml of triethylamine was added dropwise, followed by 1 h of stirring at room temperature. Then, the reaction mixture was mixed with 20 ml of water, and 18% (w/v) HCl solution was added dropwise until pH 2 was obtained. The phases were separated, the organic layer was dried over Na2SO4 and filtered, and the solvent was removed under reduced pressure. The crude product was purified by a short column chromatography (silica gel) using a solvent mixture of hexane/ethylacetate 10:1 (v:v). After removing the solvents, a colorless solid was obtained (yield, 1.8 g [92%]; mp, 32°C) (16.Fernandes R.A. Pradeep K. A stereoselective synthesis of dihydrosphingosine.Eur. J. Org. Chem. 2000; : Scopus Google Scholar, L. R. A to synthesis of and from Org. Chem. 2000; PubMed Scopus Google Scholar). was by and from different SLS patients were by the of J. A. Wanders at the of The (13.Willemsen M.A. Rotteveel J. de Jong J. Wanders R. IJlst L. Hoffmann G. Mayatepek E. Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome.J. Neurol. Sci. 2001; 183: 61-67Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar, R. C. S. Wanders R. of Sjögren-Larsson using Sci. PubMed Scopus Google Scholar). The patients the symptoms of of enzymatic activity been by of FALDH activity in and the mutations in the ALDH3A2 gene were on SLS patient cells be in Human fibroblasts from as and were by of and of the was obtained at the cells used for were purchased from Larsson Syndrome patient cells used for this are from Keller et of 1 1 2 2 are from Keller et (4.Keller M.A Watschinger K. Golderer G. Maglione M. Sarg B. Lindner H. Werner-Felmayer G. Terrinoni A. Wanders R. Werner E. Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal.J. Lipid Res. 2010; 51: 1554-1559Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar). in a not cells were at at and in an of fibroblasts and SLS patient cells were in in and with cells were in medium with and were in at a of cells in 2 ml of medium and allowed to for The cells were with of the fluorescent pyrenedecanoic acid, or were added to the medium from a solution in in a of After h of of the culture medium was into a ml and 30 of was added. The mixture was mixed and at g and for A of the mixture was into the HPLC and fluorescent were quantified as described were by of with of the fluorescent The quantification was by to the fluorescence of the a was under 30 and and The were as described After the for the culture medium the medium was removed by cells were with 1 ml and with for at was added, and the cell was into a ml were by for at and 30 of was added to the pellets followed by at and room for 1 h to the cells and the fluorescence labeled The mixture was at g for and of the was into the HPLC lipids were from cell quantification was not by to the were by the fluorescence of pyrene-labeled lipids in that was of fluorescent by on were studied with a method from and Zoeller (9.James P.F. Zoeller R. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sjogren-Larsson syndrome.J. Biol. Chem. 1997; 272: 23532-23539Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar). were in at a of in of were allowed to for and and of hexadecanol, or acid or of pyrene-labeled aldehyde, alcohol, and fatty acid were added from a solution in for The of added to the was which on cell as was by of with cells. were with the for The medium was with and cells were allowed to for was using the as of acid in medium was to concentrations for hexadecanal and to concentrations as by of the analysis was only in concentrations were to substrates and their were quantified on an HPLC using a column as described in (4.Keller M.A Watschinger K. Golderer G. Maglione M. Sarg B. Lindner H. Werner-Felmayer G. Terrinoni A. Wanders R. Werner E. Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal.J. Lipid Res. 2010; 51: 1554-1559Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar). the with a 3-fold of of the mixture was into the HPLC and with at a of After a to at was to the phase was was with at and at The of pyrene-labeled was by with a solution of the fatty aldehyde dehydrogenase activity were quantified their in to an solution of pyrenedecanoic of were obtained from cells were in medium with and cells were in with a of were to cells using in the of 1 of the were for h and and fatty aldehyde dehydrogenase were activity of were by with and in (w/v) and of a mixture were by Fatty aldehyde dehydrogenase activity was as (4.Keller M.A Watschinger K. Golderer G. Maglione M. Sarg B. Lindner H. Werner-Felmayer G. Terrinoni A. Wanders R. Werner E. Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal.J. Lipid Res. 2010; 51: 1554-1559Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar). the 20 reduced and 1 The reaction was by the of the mixture to of corresponding to of were in at in a of for of was under these The reaction was by the of 30 The of pyrenedecanoic acid formed was by HPLC with fluorescence as described control for in the extraction and for in the of fluorescent was This was were to are as was by for the quantification of fluorescent labeled or for with as analysis using Our was to the fatty aldehyde and fatty alcohol metabolism in living cells. we a novel that us to follow the fate of different fluorescent labeled in the culture medium of cells. We used the four pyrene-labeled substrates which is converted into by alkylglycerol monooxygenase (12.Watschinger K. Keller M. Golderer G. Hermann M. Maglione M. Sarg B. Lindner H. Hermetter A. Werner-Felmayer G. Konrat R. et al.Identification of the gene encoding alkylglycerol monooxygenase defines a third class of tetrahydrobiopterin-dependent enzymes.Proc. Natl. Acad. Sci. USA. 2010; 107: 13672-13677Crossref PubMed Scopus (66) Google Scholar). The formed fatty aldehyde is into pyrenedecanoic acid by FALDH (4.Keller M.A Watschinger K. Golderer G. Maglione M. Sarg B. Lindner H. Werner-Felmayer G. Terrinoni A. Wanders R. Werner E. Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal.J. Lipid Res. 2010; 51: 1554-1559Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar) or into pyrenedecanol by a fatty alcohol dehydrogenase R. C. S. Wanders R. of Sjögren-Larsson using Sci. PubMed Scopus Google Scholar). fluorescent in the in to the four quantified The four for a of the of fluorescent SLS patient fibroblasts of different were with of the fluorescent at a from as Our HPLC method was used to the that are formed for the of and SLS patient fibroblasts with of the that are in the pyrene-labeled of SLS and control cells. the is to a in SLS and control cells. The for pyrenedecanoic acid was to the and of the of and were The of fluorescent substrates we used were not to the cells. cell as by the in the of pyrene-labeled aldehyde, alcohol, and acid in to cells were and for control fibroblasts. SLS patient the corresponding cell were and the in the culture medium of cells with The control cells and the SLS cells were to readily the fatty than of the added were cells converted exclusively into the corresponding fatty acid and formed only of fatty alcohol. In contrast, in SLS cells the species was the fatty alcohol. Fatty acid was also formed to by SLS cells, to of the in the culture medium of control cells. We of pyrene-labeled alkylglycerol in SLS or control cells, fatty are for ether lipid This be to conversion of to ether in the cells. The of fatty acid to fatty alcohol with was a for the of cells to fatty aldehydes to the corresponding In the culture medium of SLS patient cells, the was control cells, the was fatty alcohol was the was used for was not on as was by The in the culture medium of living cells the with pyrenedecanol is in cells were to of the added fatty alcohol into the corresponding fatty SLS cells, in contrast, than a of the added fatty alcohol. In than of pyrenedecanoic acid was formed by SLS as with control cells. were of pyrene-labeled fatty aldehyde was in control or in SLS fibroblasts. The with pyrenedecanoic acid and are in were not to in in control and in SLS cells. A of the added was present in the culture the After measuring in the culture we the cell the lipid and with the HPLC method and The results for these are in with fluorescent in the culture and the pellets the corresponding fatty acid was formed in control cells, fatty alcohol was the product in SLS cells the of pyrene-labeled in the cell pellets to their culture medium the of the pyrene-labeled lipids added the for than and of the as fluorescent in the culture to the for analysis of fluorescent in the culture was to cells with the fatty aldehyde and to follow the of in the over a of h and the of fatty aldehyde in the medium and a formation of fatty acid in control cells. Fatty alcohol was not at In contrast, fatty alcohol with fatty acid in SLS cells with the results of the fluorescent that fatty aldehydes are readily into fatty in SLS cells, we the effect of fatty aldehyde, fatty alcohol, and fatty We the of hexadecanol, and acid We the effect of these on control and SLS cells for were lower than the for hexadecanal of hexadecanol, and acid toward control and SLS patient in a Our results show that SLS cells are to to fatty aldehydes into fatty aldehyde than fatty aldehyde dehydrogenase are to we different aldehyde into cells to their to this The results are in analysis that only fatty aldehyde dehydrogenase a enzymatic activity than the fluorescent of the results in an but not of the degradation to the was for and In we that be used to fatty aldehyde dehydrogenase activity in cell and (4.Keller M.A Watschinger K. Golderer G. Maglione M. Sarg B. Lindner H. Werner-Felmayer G. Terrinoni A. Wanders R. Werner E. Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal.J. Lipid Res. 2010; 51: 1554-1559Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar). The method we present the range of of this to monitor fatty aldehyde metabolism in the culture of living cells. Our approach of the or of formed from pyrenedecanoic acid, and glycerol in a time-dependent manner in cells in a culture We that the four quantified fluorescent in in the cell pellets and in the culture This that the of the added substrates and the quantified the cell is not a such as and be formed from the fluorescent labeled and not from column at that we to of the added fluorescent in the the four we to a of the formed under we used of fluorescent which was not to the cells. only of the culture medium and cell are this analysis be with Our that the of fluorescent labeled of living SLS patient and control cells with and pyrenedecanol The lack of fatty aldehyde dehydrogenase function in SLS patient cells to the of fatty from fatty in control cells exclusively the fatty acid was formed. control cells were to fatty into the corresponding fatty acid, by SLS patient cells. results are in with by Rizzo et (7.Rizzo W.B. Craft D. Somer T. Carney G. Trafrova J. Simon M. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.J. Lipid Res. 2008; 49: 410-419Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar, W.B. A. Craft D. Sjögren-Larsson syndrome. fatty alcohol oxidation in cultured fibroblasts to fatty oxidoreductase Clin. Invest. PubMed Scopus (102) Google Scholar), fatty alcohol in and fibroblasts of SLS patients and of SLS patient cells to fatty to The of patient cells to fatty aldehydes and the formation of base with lipids and proteins is suspected to be responsible for the symptoms of SLS (9.James P.F. Zoeller R. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sjogren-Larsson syndrome.J. Biol. Chem. 1997; 272: 23532-23539Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar). we in that control and SLS cells were to fatty aldehydes at the the sensitive fluorescent we of fatty aldehydes in cells at with fatty alcohol, fatty acid, or we that the to pyrene-labeled fatty aldehyde cells were with pyrenedecanol be to its base formation with alcohol in SLS as with control fibroblasts the to the fatty aldehyde to the acid in SLS fibroblasts impairs the metabolism of the fatty alcohol. is from the results of to SLS the fatty aldehyde and fatty alcohol on the fatty alcohol in these cells In to in which SLS patient fibroblasts were described to be toward fatty aldehydes (9.James P.F. Zoeller R. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sjogren-Larsson syndrome.J. Biol. Chem. 1997; 272: 23532-23539Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar), we not different for hexadecanol, or acid in SLS patient and control cells. were toward the fatty acid to the and a was not in fatty were than fatty aldehydes in SLS and in control cells, as is by the lower for Our that be to the biochemical action and toxicity of fatty SLS In to the of fatty in SLS patient we the formation of fatty to aldehyde are responsible for the fatty aldehyde dehydrogenase we and into cells. FALDH was to be the only aldehyde dehydrogenase to the conversion of to pyrenedecanoic acid with was a that was to over this The results of a gene expression analysis from S. J. M. E. in gene expression in fibroblasts from control and patients with by oxidative Biol. 2005; PubMed Scopus Google Scholar), that and are in the of and were and This in SLS patient only for the fatty aldehyde dehydrogenase The of to fatty aldehydes a role in SLS patient with expression has been studied in C. D. aldehyde the aldehyde dehydrogenase 2008; PubMed Scopus Google Scholar) but also expression in and T. J. a with Res. 2007; PubMed Scopus Google Scholar). are needed to a of the different aldehyde dehydrogenase in fatty aldehydes are produced by cleavage of Hermetter A. H. Golderer G. Werner-Felmayer G. of ether monooxygenase activity in by a novel Lipid Res. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar), we were also in the of fibroblasts to this lipid the method we we alkylglycerol metabolism in living SLS patient and control cells. We only of fatty acid and fatty aldehyde with The only enzyme known to be to the ether of is alkylglycerol we were to alkylglycerol monooxygenase in cell such as not in which the enzyme is (12.Watschinger K. Keller M. Golderer G. Hermann M. Maglione M. Sarg B. Lindner H. Hermetter A. Werner-Felmayer G. Konrat R. et al.Identification of the gene encoding alkylglycerol monooxygenase defines a third class of tetrahydrobiopterin-dependent enzymes.Proc. Natl. Acad. Sci. USA. 2010; 107: 13672-13677Crossref PubMed Scopus (66) Google Scholar). Rizzo et W.B Heinz E. Simon M. Craft D. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.Biochim. Biophys. Acta. 2000; 1535: 1-9Crossref PubMed Scopus (37) Google Scholar), by the use of labeled described the formation of only of fatty acids in fibroblasts. that only a role as a fatty aldehyde in fibroblasts. We present an approach to monitor fatty aldehyde dehydrogenase activity in cultured cells by of the cell culture The is an alternative to of lipids is by aliphatic lipids as in and cell PubMed Scopus Google Scholar) and be with to its with method on of the The and for and of for of fibroblasts of cells fatty aldehyde dehydrogenase Sjögren Larsson Syndrome

References

21